A Study of the Safety and Efficacy of CNTO 148 (Golimumab) in Children With Juvenile Idiopathic Arthritis (JIA) and Multiple Joint Involvement Who Have Poor Response to Methotrexate (GO KIDS)

This study has been terminated.
(Trial has failed to meet primary - and major secondary endpoints)
Sponsor:
Collaborator:
Schering-Plough
Information provided by (Responsible Party):
Janssen Research & Development, LLC
ClinicalTrials.gov Identifier:
NCT01230827
First received: October 28, 2010
Last updated: July 16, 2014
Last verified: July 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: May 2014
  Primary Completion Date: September 2013 (Final data collection date for primary outcome measure)